Merck, Bristol Myers Squibb, the U.S. Chamber of Commerce and PhRMA filed separate lawsuits against the provision last month.

Johnson & Johnson sued the Biden administration over Medicare’s new powers to slash drug prices, making it the third pharmaceutical company to challenge the controversial provision of the Inflation Reduction Act.

  • MooseBoys@lemmy.worldEnglish
    15·
    1 year ago

    when selling their property

    Except a significant portion of these drugs were developed with government (taxpayer-funded) subsidies and research grants.